Katsuhiro Shono

661 total citations
20 papers, 134 citations indexed

About

Katsuhiro Shono is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Katsuhiro Shono has authored 20 papers receiving a total of 134 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 8 papers in Public Health, Environmental and Occupational Health and 5 papers in Oncology. Recurrent topics in Katsuhiro Shono's work include Acute Lymphoblastic Leukemia research (8 papers), Acute Myeloid Leukemia Research (7 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Katsuhiro Shono is often cited by papers focused on Acute Lymphoblastic Leukemia research (8 papers), Acute Myeloid Leukemia Research (7 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Katsuhiro Shono collaborates with scholars based in Japan. Katsuhiro Shono's co-authors include Takahiro Fukuda, Toshimitsu Ueki, Saiko Kurosawa, Hiroki Yamaguchi, Masamitsu Yanada, Junya Kanda, Heiwa Kanamori, Keiko Fukunaga, Nobuhiko Uoshima and Ishikazu Mizuno and has published in prestigious journals such as Blood, Bone Marrow Transplantation and Biology of Blood and Marrow Transplantation.

In The Last Decade

Katsuhiro Shono

17 papers receiving 132 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katsuhiro Shono Japan	7	71	35	31	28	26	20	134
Yasuhito Nanya Japan	6	55 0.8×	22 0.6×	18 0.6×	22 0.8×	28 1.1×	9	115
Nicola Cantore Italy	9	84 1.2×	22 0.6×	44 1.4×	43 1.5×	41 1.6×	14	158
Sabina Sufliarska Slovakia	6	95 1.3×	57 1.6×	41 1.3×	17 0.6×	32 1.2×	15	154
Jean-Michel Cayuela France	3	107 1.5×	38 1.1×	31 1.0×	39 1.4×	15 0.6×	6	122
Feras Alfraih Saudi Arabia	8	63 0.9×	24 0.7×	40 1.3×	26 0.9×	24 0.9×	25	141
Diego V. Clé Brazil	9	79 1.1×	13 0.4×	53 1.7×	52 1.9×	26 1.0×	21	190
Luis Benlloch Spain	5	149 2.1×	37 1.1×	48 1.5×	31 1.1×	24 0.9×	10	162
K. Douglas United Kingdom	5	177 2.5×	24 0.7×	30 1.0×	15 0.5×	44 1.7×	7	194
P Vivancos Spain	9	137 1.9×	48 1.4×	38 1.2×	30 1.1×	62 2.4×	11	186
Valeria Cazzaniga Italy	4	29 0.4×	39 1.1×	15 0.5×	61 2.2×	22 0.8×	7	129

Countries citing papers authored by Katsuhiro Shono

Since Specialization

Citations

This map shows the geographic impact of Katsuhiro Shono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katsuhiro Shono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katsuhiro Shono more than expected).

Fields of papers citing papers by Katsuhiro Shono

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katsuhiro Shono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katsuhiro Shono. The network helps show where Katsuhiro Shono may publish in the future.

Co-authorship network of co-authors of Katsuhiro Shono

This figure shows the co-authorship network connecting the top 25 collaborators of Katsuhiro Shono. A scholar is included among the top collaborators of Katsuhiro Shono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katsuhiro Shono. Katsuhiro Shono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shimizu, Hiroaki, Yuho Najima, Shinichi Kako, et al.. (2024). Treatment Outcomes of Adult Patients with B-Cell Acute Lymphoblastic Leukemia Relapsed after Allogeneic Stem Cell Transplant in the Era of Novel Immunochemotherapeutic Agents. Blood. 144(Supplement 1). 3541–3541.

Toya, Takashi, Masatoshi Sakurai, Jun Kato, et al.. (2023). Differential clinical impact of letermovir prophylaxis according to graft sources: a KSGCT multicenter retrospective analysis. Blood Advances. 8(5). 1084–1093. 4 indexed citations

Ohwada, Chikako, Shingo Yamazaki, Katsuhiro Shono, et al.. (2021). Pharmacokinetically guided, once-daily intravenous busulfan in combination with fludarabine for elderly AML/MDS patients as a conditioning regimen for allogeneic stem cell transplantation. International Journal of Hematology. 114(6). 664–673. 2 indexed citations

Kurosawa, Saiko, Takuhiro Yamaguchi, Takehiko Mori, et al.. (2021). Resignation and return to work in patients receiving allogeneic hematopoietic cell transplantation close up. Journal of Cancer Survivorship. 16(5). 1004–1015. 7 indexed citations

Akahoshi, Yu, Yasuyuki Arai, Satoshi Nishiwaki, et al.. (2021). Newly proposed threshold and validation of white blood cell count at diagnosis for Philadelphia chromosome-positive acute lymphoblastic leukemia: risk assessment of relapse in patients with negative minimal residual disease at transplantation—a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSTCT. Bone Marrow Transplantation. 56(11). 2842–2848. 4 indexed citations

Kikuchi, Taku, Takehiko Mori, Chikako Ohwada, et al.. (2020). Pharmacokinetics of intravenous busulfan as condition for hematopoietic stem cell transplantation: comparison between combinations with cyclophosphamide and fludarabine. International Journal of Hematology. 113(1). 128–133. 5 indexed citations

Sakaguchi, Masahiro, Hiroki Yamaguchi, Yuho Najima, et al.. (2020). The sensitivity of the FLT3-ITD detection method is an important consideration when diagnosing acute myeloid leukemia. Leukemia Research Reports. 13. 100198–100198. 10 indexed citations

Akahoshi, Yu, Satoshi Nishiwaki, Yasuyuki Arai, et al.. (2020). Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSHCT. Bone Marrow Transplantation. 55(7). 1317–1325. 12 indexed citations

Kako, Shinichi, Yoshinobu Kanda, Makoto Onizuka, et al.. (2018). Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia with Pre-Transplant Conditioning Using Fludarabine, Reduced-Dose Cyclophosphamide, and Low-Dose Thymoglobulin:Â Ksgct Prospective Study. Blood. 132(Supplement 1). 2101–2101.

10.

Kayamori, Kensuke, et al.. (2018). Efficacy and tolerability of rituximab and reduced-dose cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy for elderly patient with diffuse large B-cell lymphoma. Hematology. 24(1). 52–59. 5 indexed citations

11.

Yui, Shunsuke, Saiko Kurosawa, Hiroki Yamaguchi, et al.. (2017). D816 mutation of the KIT gene in core binding factor acute myeloid leukemia is associated with poorer prognosis than other KIT gene mutations. Annals of Hematology. 96(10). 1641–1652. 32 indexed citations

12.

Kurosawa, Saiko, Hiroki Yamaguchi, Takuhiro Yamaguchi, et al.. (2016). Decision Analysis of Postremission Therapy in Cytogenetically Intermediate-Risk Acute Myeloid Leukemia: The Impact of FLT3 Internal Tandem Duplication, Nucleophosmin, and CCAAT/Enhancer Binding Protein Alpha. Biology of Blood and Marrow Transplantation. 22(6). 1125–1132. 18 indexed citations

13.

Kurimoto, Ryota, et al.. (2016). <i>MYC/BCL2</i> Double-hit Lymphoma in a Patient with Rheumatoid Arthritis Associated with Methotrexate Treatment. Internal Medicine. 55(16). 2271–2275. 2 indexed citations

14.

Yano, Shingo, Takehiko Mori, Yoshinobu Kanda, et al.. (2015). Favorable survival after allogeneic stem cell transplantation with reduced-intensity conditioning regimens for relapsed/refractory follicular lymphoma. Bone Marrow Transplantation. 50(10). 1299–1305. 6 indexed citations

15.

Kurosawa, Saiko, Hiroki Yamaguchi, Takuhiro Yamaguchi, et al.. (2014). Decision Analysis of Allogeneic Hematopoietic Stem Cell Transplantation Versus Chemotherapy in Cytogenetically Standard-Risk Acute Myeloid Leukemia in First Complete Remission: The Impact of FLT3-ITD Profile. Blood. 124(21). 1221–1221. 1 indexed citations

16.

Kumagai, Jin, et al.. (2013). Acute Myelogenous Leukemia with <i>Leptotrichia trevisanii</i> Bacteremia. Internal Medicine. 52(22). 2573–2576. 13 indexed citations

17.

Shono, Katsuhiro. (2003). Disseminated Fusarium solani Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation. Nippon Ishinkin Gakkai Zasshi. 44(3). 187–191. 2 indexed citations

18.

Nakao, Makoto, Misa Nakamura, Yuko Nishimoto, et al.. (2001). Technical aspects of pig model in living-related small intestinal transplantation. Asian Journal of Surgery. 24(4). 353–356. 5 indexed citations

19.

Kubota, Masayuki, et al.. (1999). Helicobacter pylori infection in postoperative patients with biliary atresia. Pediatric Surgery International. 15(3-4). 210–213.

20.

Tajiri, Tatsuro, Sachiyo Suita, Katsuhiro Shono, et al.. (1999). Lung Cancer in a Child with a Substantial Family History of Cancer. European Journal of Pediatric Surgery. 9(6). 409–412. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact